Android app Apple app link

Ionis Pharmaceuticals, Inc. (IONS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$81.81

$2.24 (2.82%)
Last update: 01:41 PM EST
Day's range
$79.09
Day's range
$82.09

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/17/2025 RBC Capital Luca Issi $95.00 $78.37   21.22%
10/08/2025 Oppenheimer Justin Kim $90.00 $68.94   30.55%
09/23/2025 Barclays Gena Wang $82.00 $61.36   33.64%
09/22/2025 Raymond James Gary Nachman $75.00 $61.36   22.23%
09/03/2025 BMO Capital Kostas Biliouris $70.00 $60.49   15.72%
09/02/2025 Barclays Gena Wang $78.00 $57.49   35.68%
09/02/2025 Morgan Stanley Michael Ulz $71.00 $57.49   23.5%
09/02/2025 H.C. Wainwright Mitchell Kapoor $95.00 $57.49   65.25%
08/22/2025 Wells Fargo Yanan Zhu $82.00 $42.69   92.08%
10/09/2024 Guggenheim Debjit Chattopadhyay $65.00 $37.80   71.96%
08/02/2024 BMO Capital Kostas Biliouris $60.00 $51.32   16.91%
07/24/2024 Leerink Partners Mani Foroohar $62.00 $51.86   19.55%
07/22/2024 Jefferies Akash Tewari $77.00 $50.61   52.14%
07/22/2024 Goldman Sachs Salveen Richter $33.00 $50.61   -34.8%
07/16/2024 Jefferies Akash Tewari $75.00 $49.84   50.48%
06/27/2024 Stifel Nicolaus Paul Matteis $53.00 $47.70   11.11%
06/17/2024 RBC Capital Luca Issi $70.00 $40.63   72.29%
06/14/2024 Tudor Pickering William Pickering $44.00 $41.12   7%
05/17/2024 BMO Capital Kostas Biliouris $67.00 $36.84   81.87%
06/21/2022 Piper Sandler Do Kim $55.00 $37.56   46.43%
02/23/2022 RBC Capital Luca Issi $67.00 $32.49   106.22%
02/23/2022 Needham Joseph Stringer $60.00 $32.49   84.67%
01/31/2022 Bank of America Securities Jason Gerberry $30.00 $31.51   -4.79%
11/03/2021 Barclays Gena Wang $33.00 $34.63   -4.71%
10/17/2021 Laidlaw Yale Jen $68.00 $30.25   124.79%
05/09/2021 UBS Esther Rajavelu $37.50 $36.24   3.48%
05/04/2021 Oppenheimer Kevin DeGeeter $63.00 $39.89   57.93%

Ionis Pharmaceuticals, Inc. FAQ's

Ionis Pharmaceuticals, Inc. has been rated by research analysts at RBC Capital, Leerink Partners, Piper Sandler, H.C. Wainwright, Morgan Stanley, Cowen & Co. in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.